What would you do with €100 million?

Mobile Version

OfficialLotto

Mayside Research

Tuesday, February 9, 2010

"In all affairs it's a healthy thing now and then to hang a question mark on the things you have long taken for granted."— Bertrand Russell, (1872 - 1970)
SUBMIT PRESS RELEASE
Body Found Dead On Delta Flight
BREAKING NEWS OP-ED BUSINESS SPORT LIFE LEISURE KNOWLEDGE POLITICS GOV44.COM OBITUARIES PRESS RELEASES  
JOURNALIST REGISTRATION LOGIN SIGN UP

Arena Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals And Alliances Profile - New Report Published

Newly released report, Arena Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile, provides detailed company analysis

Published on November 23, 2009

by Press Office

(Companiesandmarkets.com and OfficialWire)

LONDON, ENGLAND

Re-Tweet this article
 

Arena Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Arena Pharmaceuticals, Inc., (Arena) is engaged in research and development of innovative therapies for the treatment of various diseases including obesity, diabetes, insomnia, thrombosis. It is a biopharmaceutical company conducting research programs in major therapeutic areas including central nervous system, cardiovascular, inflammatory and metabolic diseases. The company is in development stage with all the product candidates in clinical trials. It generates revenue from collaborative agreements with Ortho McNeil and Merck. It is focusing on its broad product pipeline targeting orphan G protein coupled receptors (GPCR).

The Arena Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers' businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors' business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.

Arena Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile: http://www.companiesandmarkets.com/r.ashx?id=8YJN38UVU166677

Contact
CompaniesandMarkets.com
Mike King
info@companiesandmarkets.com
Tel: +44 203 086 8600




Posted   11/23/2009 7:41 AM


    
 



Print ArticlePrint EmailEmail Post to DiggPost to Digg
Print ArticleRE-PRINT PERMISSION RSS Local RSS Feed

All form fields are required.

OfficialWire is not storing your Twitter login data!

What would you do with €100 million?

You are here:HomePRESS RELEASES Global Finance